NovaBiotics is a leading clinical stage biotechnology company focused on the design and development of first-in-class anti-infective therapies for difficult to treat, poorly served infectious conditions. Our rational drug design approach and unique patented peptide anti-infective technology has already been validated through successful clinical development of the company's lead compound, Novexatin®, a topical (brush on) treatment for fungal nail infections.